Metformin Restores Parkin-Mediated Mitophagy, Suppressed by Cytosolic p53
Open accessThe DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Metformin is known to alleviate hepatosteatosis by inducing 5’ adenosine monophosphate (AMP)-kinase-independent, sirtuin 1 (SIRT1)-mediated autophagy. Dysfunctional mitophagy in response to glucolipotoxicities might play an important role in hepatosteatosis. Here, we investigated the mechanism by which metformin induces mitophagy through restoration of the suppressed Parkin-mediated mitophagy. To this end, our ob/ob mice were divided into three groups: (1) ad libitum feeding of a standard chow diet; (2) intraperitoneal injections of metformin 300 mg/kg; and (3) 3 g/day caloric restriction (CR). HepG2 cells were treated with palmitate (PA) plus high glucose in the absence or presence of metformin. We detected enhanced mitophagy in ob/ob mice treated with metformin or CR, whereas mitochondrial spheroids were observed in mice fed ad libitum. Metabolically stressed ob/ob mice and PA-treated HepG2 cells showed an increase in expression of endoplasmic reticulum (ER) stress markers and cytosolic p53. Cytosolic p53 inhibited mitophagy by disturbing the mitochondrial translocation of Parkin, as demonstrated by immunoprecipitation. However, metformin decreased ER stress and p53 expression, resulting in induction of Parkin-mediated mitophagy. Furthermore, pifithrin-α, a specific inhibitor of p53, increased mitochondrial incorporation into autophagosomes. Taken together, these results indicate that metformin treatment facilitates Parkin-mediated mitophagy rather than mitochondrial spheroid formation by decreasing the inhibitory interaction with cytosolic p53 and increasing degradation of mitofusins.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“metformin induces enhanced autophagic responses in δ-Sarcoglycan deficiency-induced dilated cardiomyopathic mouse hearts and enhanced mitophagy in ob/ob mice”
From Benefits of Metformin in Attenuating the Hallmarks of Aging (2020) · cites this paper as Song et al. 2016
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities
Sanyal, A. J., Campbell–Sargent, C., Mirshahi, F., Rizzo, W. B., Contos, M. J., Sterling, R. K., Luketic, V. A., Shiffman, M. L., & Clore, J. N. (2001) · Gastroenterology · doi:10.1053/gast.2001.23256 · Cited by 2,078 · cited 1×
“Regarding fat accumulation in the liver, each hepatocyte contains about 800 mitochondria, and mitochondrial dysfunction can contribute to the development of NAFLD [21–23].”
BackgroundVousden, K. H., & Ryan, K. M. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2715 · Cited by 959
Suzuki, S., Tanaka, T., Poyurovsky, M. V., Nagano, H., Mayama, T., Ohkubo, S., Lokshin, M., Hosokawa, H., Nakayama, T., Suzuki, Y., et al. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1002459107 · Cited by 705 · cited 3×
“In addition, recent studies have reported that cytosolic p53 interferes with mitochondrial integrity and mitophagy [6,7] by inhibiting the removal of damaged mitochondria through an i hibitory interaction with Parkin, thereby inducing itochon rial dysfunction [8,9].”
BackgroundHoshino, A., Mita, Y., Okawa, Y., Ariyoshi, M., Iwai-Kanai, E., Ueyama, T., Ikeda, K., Ogata, T., & Matoba, S. (2013) · Nature Communications · doi:10.1038/ncomms3308 · Cited by 536 · cited 3×
“In addition, recent studies have reported that cytosolic p53 interferes with mitochondrial integrity and mitophagy [6,7] by inhibiting the removal of damaged mitochondria through an i hibitory interaction with Parkin, thereby inducing itochon rial dysfunction [8,9].”
BackgroundAutophagosome Formation and Molecular Mechanism of Autophagy
Tanida, I. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3482 · Cited by 493
Rector, R. S., Thyfault, J. P., Uptergrove, G. M., Morris, E. M., Naples, S. P., Borengasser, S. J., Mikus, C. R., Laye, M. J., Laughlin, M. H., Booth, F. W., et al. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.030 · Cited by 488
Adrain, C. (2001) · The EMBO Journal · doi:10.1093/emboj/20.23.6627 · Cited by 441 · cited 1×
“Fractionation to separate the mitochondrial and cytosolic fractions was carried out as previously described [27].”
Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease
Ren, J., Pulakat, L., Whaley-Connell, A., & Sowers, J. R. (2010) · Journal of Molecular Medicine · doi:10.1007/s00109-010-0663-9 · Cited by 367 · cited 1×
“4) for 1 h at room temperature, and dehydrated with a graded series of ethanol, as previously described [5].”
MethodSong, Y. M., Lee, Y.-H., Kim, J.-W., Ham, D.-S., Kang, E.-S., Cha, B. S., Lee, H. C., & Lee, B.-W. (2015) · Autophagy · doi:10.4161/15548627.2014.984271 · Cited by 332 · cited 2×
“Recently, we demonstrated that metformin activates lipophagy, resulting in relief of hepatosteatosis due to induction of SIRT1-mediated autophagy independent of AMP-activated protein kinase [1].”
BackgroundSelf-citationAfter the banquet: Mitochondrial biogenesis, mitophagy, and cell survival
Zhu, J., Wang, K. Z., & Chu, C. T. (2013) · Autophagy · doi:10.4161/auto.24135 · Cited by 293
Cited by
Mechanisms of mitophagy in cellular homeostasis, physiology and pathology
Palikaras, K., Lionaki, E., & Tavernarakis, N. (2018) · Nature Cell Biology · doi:10.1038/s41556-018-0176-2 · Cited by 1,472
Benefits of Metformin in Attenuating the Hallmarks of Aging
Kulkarni, A. S., Gubbi, S., & Barzilai, N. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.04.001 · Cited by 766
Lou, G., Palikaras, K., Lautrup, S., Scheibye-Knudsen, M., Tavernarakis, N., & Fang, E. F. (2020) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2019.07.002 · Cited by 452
PINK1/Parkin-mediated mitophagy in neurodegenerative diseases
Li, J., Yang, D., Li, Z., Zhao, M., Wang, D., Sun, Z., Wen, P., Dai, Y., Gou, F., Ji, Y., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101817 · Cited by 383
Mitophagy in Alzheimer’s Disease and Other Age-Related Neurodegenerative Diseases
Cai, Q., & Jeong, Y. Y. (2020) · Cells · doi:10.3390/cells9010150 · Cited by 265
Mitophagy in Alzheimer’s disease: Molecular defects and therapeutic approaches
Mary, A., Eysert, F., Checler, F., & Chami, M. (2023) · Molecular Psychiatry · doi:10.1038/s41380-022-01631-6 · Cited by 244
Doblado, L., Lueck, C., Rey, C., Samhan-Arias, A. K., Prieto, I., Stacchiotti, A., & Monsalve, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083903 · Cited by 228
p53 Deacetylation Alleviates Sepsis-Induced Acute Kidney Injury by Promoting Autophagy
Sun, M., Li, J., Mao, L., Wu, J., Deng, Z., He, M., An, S. L., Zeng, Z., Huang, Q., & Chen, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.685523 · Cited by 177
Mitochondrial oxidative function in NAFLD: Friend or foe?
Shum, M., Ngo, J., Shirihai, O. S., & Liesa, M. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101134 · Cited by 106
“Moreover, current drugs improving steatosis and NASH in humans, such as metformin and liraglutide, increase mitophagy in rodent models of simple steatosis and NASH [95,96].”
BackgroundLee, Y.-H., Kim, J. H., Kim, S. R., Jin, H. Y., Rhee, E.-J., Cho, Y. M., & Lee, B.-W. (2017) · Journal of Korean Medical Science · doi:10.3346/jkms.2017.32.1.60 · Cited by 104
“For example, lobeglitazone may play a role in decreasing the availability of plasma fatty acids arising from adipose tissue through abated lipolysis and the positive distribution of fat mass; on the other hand, metformin may activate either fatty acid oxidation or lipophagy, as well as mitophagy, via upregulation of t…”
BackgroundSelf-citationRole of mitochondrial quality control in the pathogenesis of nonalcoholic fatty liver disease
Li, R., Toan, S., & Zhou, H. (2020) · Aging · doi:10.18632/aging.102972 · Cited by 87
“response to HFD through Parkin-induced mitophagy [180].”
Metformin mediates cardioprotection against aging‐induced ischemic necroptosis
Li, C., Mu, N., Gu, C., Liu, M., Yang, Z., Yin, Y., Chen, M., Wang, Y., Han, Y., Yu, L., et al. (2020) · Aging Cell · doi:10.1111/acel.13096 · Cited by 83
“Metformin, a potential anti-aging agent, is thought to accelerate autophagy (Song et al., 2016).”
BackgroundMitochondrial quality control in AMD: does mitophagy play a pivotal role?
Hyttinen, J. M. T., Viiri, J., Kaarniranta, K., & Błasiak, J. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2843-7 · Cited by 88
Babak, M. V., Chong, K. R., Rapta, P., Ζαννίκου, Μ., Tang, H. M., Reichert, L., Chang, M. R., Kushnarev, V. A., Heffeter, P., Meier, S. M., et al. (2021) · Angewandte Chemie International Edition · doi:10.1002/anie.202102266 · Cited by 74
Huang, C., Yan, S., & Zhang, Z. (2020) · Translational Neurodegeneration · doi:10.1186/s40035-020-00219-w · Cited by 79
Mitophagy in depression: Pathophysiology and treatment targets
Tripathi, A., Scaini, G., Barichello, T., Quevedo, J., & Pillai, A. (2021) · Mitochondrion · doi:10.1016/j.mito.2021.08.016 · Cited by 75
Mitophagy: A promising therapeutic target for neuroprotection during ageing and age‐related diseases
Mishra, E., & Thakur, M. K. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16062 · Cited by 77
Metwally, A., Radi, A. A., El-Shazoly, R. M., & Hamada, A. M. (2018) · Journal of Plant Research · doi:10.1007/s10265-018-1008-y · Cited by 66
Rizzo, F., Ronchi, D., Salani, S., Nizzardo, M., Fortunato, F., Bordoni, A., Stuppia, G., Bo, R. D., Piga, D., Fato, R., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw258 · Cited by 72
“Because the inhibition of p53 signalling promotes mitochondrial clearance (49), we decided to investigate whether this mechanism occurs in CMT2A-MNs and is related to the previously documented reduction in mitochondrial content.”
BackgroundMechanisms and Functions of Mitophagy and Potential Roles in Renal Disease
Zuo, Z., Jing, K., Wu, H.-L., Wang, S., Ye, L., Li, Z., Yang, C., Pan, Q., Liu, W. J., & Liu, H. (2020) · Frontiers in Physiology · doi:10.3389/fphys.2020.00935 · Cited by 65
The p53 Pathway and Metabolism: The Tree That Hides the Forest
Lahalle, A., Lacroix, M., Blasio, C. D., Cissé, M. Y., Linares, L. K., & Cam, L. L. (2021) · Cancers · doi:10.3390/cancers13010133 · Cited by 76
Miricescu, D., Bădoiu, S. C., Stănescu-Spînu, I.-I., Totan, A., Ștefani, C., & Greabu, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179512 · Cited by 73
“By increasing the protein synthesis rate [174,181], decreasing insulin resistance [175,176], and controlling hyperglycemia [174], metformin creates the metabolic premises for better and faster healing of the wounds and facilitates the skin graft take.”
BackgroundMolecular mechanisms of mitophagy and its roles in neurodegenerative diseases
Li, X., Huang, L., Lan, J., Feng, X., Li, P., Wu, L., & Peng, Y. (2021) · Pharmacological Research · doi:10.1016/j.phrs.2020.105240 · Cited by 57
Gupta, P., Sharma, G., Lahiri, A., & Barthwal, M. K. (2021) · Journal of Leukocyte Biology · doi:10.1002/jlb.3a0620-348rr · Cited by 60
Wang, X., Zhang, J., Xiu, C., Yang, J., Fang, J., & Lei, Y. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/7151946 · Cited by 57
“have found that metabolic stressed ob/ob mice and HG/PA-treated HepG2 cells showed inhibition of mitophagy by disturbing translocation of Parkin to mitochondria [38].”
BackgroundYang, F., Wang, X., Yang, D., Lu, Y., Wei, G., Yu, W., Liu, X., Zheng, Q., Ying, J., & Hua, F. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.738686 · Cited by 56
“Metformin plays a beneficial role by activating SIRT1-mediated, AMPK-independent autophagy pathways, and also combats the inhibition of intracytoplasmic P53 on parkinmediated mitophagy, thus maintain mitochondrial quality (Song et al., 2016).”
BackgroundLal, J. C., Mao, C., Zhou, Y., Gore-Panter, S. R., Rennison, J. H., Lovano, B. S., Castel, L., Shin, J., Gillinov, A. M., Smith, J. D., et al. (2022) · Cell Reports Medicine · doi:10.1016/j.xcrm.2022.100749 · Cited by 50
Mitochondria in Retinal Ganglion Cells: Unraveling the Metabolic Nexus and Oxidative Stress
Yang, T.-H., Kang, E. Y., Lin, P., Yu, B. B.-C., Wang, J. H.-H., Chen, V., & Wang, N. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168626 · Cited by 67
“…pathway in local mitophagy [197] Mice (Obesity) Metformin Reduced ER stress and p53 levels to restore Parkin-mediated mitophagy in hepatocytes [198] Rat (Glaucoma) Overexpression Opa1 with AAV2-OPA1 Upregulated Parkin, leading to a greater mitochondrial surface area, better mitochondria…”
BackgroundSelf-citationTriggering of Parkin Mitochondrial Translocation in Mitophagy: Implications for Liver Diseases
Eid, N. A. S., Ito, Y., & Otsuki, Y. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00100 · Cited by 47
“…of ob/ob mice (a genetic model for NAFL) with metformin was found to enhance prosurvival mitophagy in hepatocytes by suppressing the inhibitory interaction of cytosolic p53 with Parkin, allowing Parkin mitochondrial translocation and increasing the degradation of mitofusins (Song et al., 2016).”
BackgroundMechanisms of Mitochondrial Malfunction in Alzheimer’s Disease: New Therapeutic Hope
Nabi, S. U., Khan, A., Siddiqui, E. M., Rehman, M. U., Alshahrani, S., Arafah, A. M., Mehan, S., Alsaffar, R. M., Alexiou, A. T., & Shen, B. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4759963 · Cited by 55
“Metformin (Met) Facilitates Parkin-mediated mitophagy, induces AMPK-independent and SIRT1-mediated pathway Yes [279]”
Mitophagy and Mitochondrial Quality Control Mechanisms in the Heart
Gottlieb, R. A., & Thomas, A. (2017) · Current Pathobiology Reports · doi:10.1007/s40139-017-0133-y · Cited by 50
Mitophagy and Oxidative Stress in Cancer and Aging: Focus on Sirtuins and Nanomaterials
Vernucci, E., Tomino, C., Molinari, F., Limongi, D., Aventaggiato, M., Sansone, L., Tafani, M., & Russo, M. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/6387357 · Cited by 48
“Metformin Increase Decreases the inhibitory interaction between Parkin and p53 and increase the degradation of mitofusins [10]”
Bhansali, S., Bhansali, A., & Dhawan, V. (2020) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14141 · Cited by 44
Farghaly, F. A., Salam, H. K., Hamada, A. M., & Radi, A. A. (2020) · Scientia Horticulturae · doi:10.1016/j.scienta.2020.109867 · Cited by 48
Zhao, Y., & Sun, M. (2020) · Life Sciences · doi:10.1016/j.lfs.2020.117382 · Cited by 47
Mitophagy in neurodegenerative disease pathogenesis
Yang, K., Yan, Y., Yu, A., Zhang, R., Zhang, Y., Qiu, Z., Li, Z., Zhang, Q., Wu, S., & Li, F. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.385281 · Cited by 47
“Metformin treatment benefits Parkin-mediated mitophagy by promoting the degradation of mitofusins and shutting down the inhibitory interaction of cytosolic p53 with Parkin in an obese mouse model (Song et al., 2016).”
BackgroundMolecular Mechanism of Autophagy: Its Role in the Therapy of Alzheimer’s Disease
Zhao, Y., Zhang, Y., Zhang, J., Zhang, X., & Yang, G. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200114163636 · Cited by 41
“Metformin also decreases the inhibitory interaction with cytosolic p53 by facilitating Parkin-mediated mitophagy [183].”
BackgroundRole of mitophagy in the neurodegenerative diseases and its pharmacological advances: A review
Wang, Q., Xue, H., Yue, Y., Hao, S., Huang, S., & Zhang, Z. (2022) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2022.1014251 · Cited by 38
“Metformin stimulates mitophagy by restoring mTOR-dependent autophagy activation and Parkin-mediated mechanisms (Song et al., 2016).”
BackgroundPINK1 signaling in mitochondrial homeostasis and in aging (Review)
Kitagishi, Y., Nakano, N., Ogino, M., Ichimura, M., Minami, A., & Matsuda, S. (2017) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2016.2827 · Cited by 38
“In addition, metformin is known to improve hepatosteatosis by inducing Sirt1-mediated mitophagy (68).”
BackgroundLi, X., Wu, Z., Si, X., Li, J., Wu, G., & Wang, M. (2025) · European journal of medical research · doi:10.1186/s40001-025-02699-w · Cited by 53
“…extracted from Rhodiola rosea roots and having multiple pharmacological activities, promotes mitochondrial autophagy and maintains homeostasis in AD models, alleviating Aβ pathology and cognitive deficits by binding NRF2 and blocking its interaction with Keap1 to enhance SIRT3 transcription [231].”
Casieri, V., Matteucci, M., Cavallini, C., Torti, M., Torelli, M., & Lionetti, V. (2017) · Scientific Reports · doi:10.1038/s41598-017-13949-1 · Cited by 38
Li, S.-M. H., Liu, S., Chang, Y., Ho, C., & Huang, S. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0478-5 · Cited by 41
Defective Autophagy and Mitophagy in Alzheimer’s Disease: Mechanisms and Translational Implications
Chen, J., He, H., Ye, Q., Feng, F., Wang, W., Gu, Y., Han, R., & Xie, C. (2021) · Molecular Neurobiology · doi:10.1007/s12035-021-02487-7 · Cited by 37
Huang, W., Xie, W., Zhong, H., Cai, S., Huang, Q., Liu, Y., Zeng, Z., & Liu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.859231 · Cited by 42
Roles of microglial mitophagy in neurological disorders
Liu, Y., Wang, M., Hou, X., & Hu, L. (2022) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2022.979869 · Cited by 36
Chemical mitophagy modulators: Drug development strategies and novel regulatory mechanisms
Dong, Y. J., Zhuang, X., Wang, Y.-T., Tan, J., Feng, D., Li, M., Zhong, Q., Song, Z., Shen, H., Fang, E. F., et al. (2023) · Pharmacological Research · doi:10.1016/j.phrs.2023.106835 · Cited by 39
Culprit or Bystander: Defective Mitophagy in Alzheimer’s Disease
Xie, C., Aman, Y., Adriaanse, B. A., Cader, M. Z., Plun‐Favreau, H., Xiao, J., & Fang, E. F. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00391 · Cited by 29
“These disease pathologies can further cause the damage of mitochondria and the inhibition of mitophagy, thus, generating a vicious cycle. and boost mitochondrial biogenesis through Parkin-mediated mitophagy induction via p53 inhibition (Song et al., 2016; Palikaras et al., 2018).”
BackgroundMdm2 enhances ligase activity of parkin and facilitates mitophagy
Kook, S., Zhan, X., Thibeault, K. C., Ahmed, M. R., Gurevich, V. V., & Gurevich, E. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-61796-4 · Cited by 34
González, L. F., Bevilacqua, L. E., & Naves, R. F. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13122055 · Cited by 32
Berdowska, I., Matusiewicz, M., & Fecka, I. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062394 · Cited by 35
Mitochondrial mechanisms in Alzheimer’s disease: Quest for therapeutics
Kalani, K., Chaturvedi, P., Chaturvedi, P., Verma, V. K., Lal, N., Awasthi, S. K., & Kalani, A. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103547 · Cited by 30
Macroautophagy and Mitophagy in Neurodegenerative Disorders: Focus on Therapeutic Interventions
Magalhães, J. D., Fão, L., Vilaça, R., Cardoso, S. M., & Rego, A. C. (2021) · Biomedicines · doi:10.3390/biomedicines9111625 · Cited by 30
“For instance, metformin stimulates mitophagy by restoring mTOR-dependent activation of autophagy and the Parkin-mediated mechanism [364].”
BackgroundThe Role of Mitophagy in Glaucomatous Neurodegeneration
Stavropoulos, D., Grewal, M. K., Petriti, B., Chau, K., Hammond, C. J., Garway‐Heath, D. F., & Lascaratos, G. (2023) · Cells · doi:10.3390/cells12151969 · Cited by 29
CLEC16A—An Emerging Master Regulator of Autoimmunity and Neurodegeneration
Pandey, R., Bakay, M. A., & Hakonarson, H. H. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24098224 · Cited by 32
Almendáriz-Palacios, C., Mousseau, D. D., Eskiw, C. H., & Gillespie, Z. E. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21239220 · Cited by 31
“CR and metformin have common physiological impacts; for example, obese mice under CR and treated with metformin exhibit mitophagy and reduced oxidative stress [298].”
BackgroundResultInfluentialNita, M., & Grzybowski, A. E. (2020) · EXCLI journal · doi:10.17179/excli2020-2915 · Cited by 25
“Cell death induced by the excessive ROS production and the oxidative stress is involved in pathomechanism of many general neurodegenerative pathologies such as Alzheimer’s disease (Butterfield et al., 2001), Parkinson’s disease (Onyango, 2008), prion disease (Kim et al., 2001), protein misfolding diseases (Tabner et a…”
BackgroundInfluentialMitophagy in Hypertension-Associated Premature Vascular Aging
Schreckenberger, Z. J., Wenceslau, C. F., Joe, B., & McCarthy, C. G. (2020) · American Journal of Hypertension · doi:10.1093/ajh/hpaa058 · Cited by 22
Cellular Protein Quality Control in Diabetic Cardiomyopathy: From Bench to Bedside
Kaur, N., Raja, R., Ruiz‐Velasco, A., & Liu, W. (2020) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2020.585309 · Cited by 24
“In pancreatic islets and hepatocytes from obese mice, an increase in P53 protein suppressed mitophagy by direct interaction of P53 and PRKN, blunting mitochondrial uptake by autophagosomes (339, 340).”
BackgroundZhao, S., Wu, Y., Wei, Y., Xu, X., & Zheng, J. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.876616 · Cited by 23
“P53 is known to regulate autophagy, according to previous studies (48).”
BackgroundYang, L., Lu, P., Qi, X., Yang, Q., Liu, L., Dou, T., Guan, Q., & Yu, C. (2023) · iScience · doi:10.1016/j.isci.2023.108082 · Cited by 21
“29 Previous studies have indicated that metformin prevents the occurrence of ER stress in hepatocytes of obese mice 30 and has anti-inflammatory effects in various tissues, including adipose, liver, and testis, where it inhibits cellular production of tumor necrosis factor alpha (TNF-a ) and…”
BackgroundMitochondrial stress response in drug-induced liver injury
Zheng, J., Yuan, Q., Zhou, C., Huang, W., & Yu, X. M. (2021) · Molecular Biology Reports · doi:10.1007/s11033-021-06674-6 · Cited by 22
Efentakis, P., Psarakou, G., Varela, A., Papanagnou, E., Chatzistefanou, M., Nikolaou, P., Davos, C. H., Gavriatopoulou, M., Trougakos, I. P., Dimopoulos, M. A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222010956 · Cited by 20
Mitochondrial DNA: a molecular switch driving sterile neuroinflammation
Jauhari, A., Singh, T., Carlisle, D. L., & Friedlander, R. M. (2026) · Translational Neurodegeneration · doi:10.1186/s40035-026-00540-w · Cited by 21
The Present and Future of Mitochondrial-Based Therapeutics for Eye Disease
Ji, M. H., Kreymerman, A., Belle, K. C., Ghiam, B. K., Muscat, S. P., Mahajan, V. B., Enns, G. M., Mercola, M. A., & Wood, E. H. (2021) · Translational Vision Science & Technology · doi:10.1167/tvst.10.8.4 · Cited by 20
Inhibition of mitochondrial OMA1 ameliorates osteosarcoma tumorigenesis
Chen, L., Chen, D., Pan, Y., Mo, Y., Lai, B., Chen, H., Zhang, D., & Xia, X.-D. (2024) · Cell Death and Disease · doi:10.1038/s41419-024-07127-1 · Cited by 17
Delineating the Role of Mitophagy Inducers for Alzheimer Disease Patients
Wang, W., Han, R., He, H., Wang, Z., Luan, X., Li, J., Feng, L., Chen, S., Aman, Y., & Xie, C. (2021) · Aging and Disease · doi:10.14336/ad.2020.0913 · Cited by 15
“Aging and Disease • Volume 12, Number 3, June 2021 857 Rapamycin C51H79NO13 Increasing the translocation of p62 and Parkin to the damaged mitochondria No [85] Toxic Phenylhydrazones carbonyl cyanide m-chlorophenyl hydrazone (CCCP) C9H5ClN4 C10H5F3N4O5 FCCP: R1=H; R2=OCF3 CCCP: R1=CI; R2=H Proton-leak-induced loss ofΔΨ…”
BackgroundLi, W., Zhang, Y., Wang, X., Cao, J., Qian, W., Ling, G., Tan, N., Jiang, J., Sun, Q., Li, C., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/4344677 · Cited by 15
“In addition, it has been reported that p53 binds to Parkin in the cytoplasm, thereby inhibiting Parkin ’ s transfer to mitochondria, leading to mitophagy blockage [19, 32].”
Palikaras, K., Princz, A., & Tavernarakis, N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.62137-2 · Cited by 16
“2) (Song et al., 2016).”
Dominiak, A., Gawinek, E., Banaszek, A. A., & Wilkaniec, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26178693 · Cited by 16
“Other strategies, such as inducing mild bioenergetic stress with agents like 2-deoxyglucose [176] or mitochondrial uncou-plers [177], or using autophagy enhancers like rapamycin and metformin, have also been shown to activate mitophagy and mitigate neurodegenerative phenotypes [178–180].”
Abdullaev, S. A., Minkabirova, G., Карманова, Е. Е., Брусков, В. И., & Gaziev, A. I. (2018) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2018.05.006 · Cited by 12
Is Disrupted Mitophagy a Central Player to Parkinson’s Disease Pathology?
Ko, T. K., & Tan, D. J. Y. (2023) · Cureus · doi:10.7759/cureus.35458 · Cited by 12
“One possible research avenue that would be of particular interest is the restoration of dysfunctional parkin-mediated mitophagy that has been seen with the antidiabetic medication metformin [160].”
BackgroundInduction of Autophagy as a Therapeutic Breakthrough for NAFLD: Current Evidence and Perspectives
Liu, Y., Zhang, M., & Wang, Y. (2025) · Biology · doi:10.3390/biology14080989 · Cited by 15
“It can also promote Parkin-mediated mitophagy, improving hepatic lipid metabolism [71].”
Mitophagy stimulation as a novel strategy for the treatment of mitochondrial diseases
Lee, K., & Yun, J. (2022) · Journal of genetic medicine · doi:10.5734/jgm.2022.19.2.49 · Cited by 9
Wang, Y., Song, D., & Tang, L. (2023) · Journal of Inflammation Research · doi:10.2147/jir.s402290 · Cited by 8
“Improving mitophagy by metformin or antioxidants may prevent DKD kidney damage.(49,54,55)”
BackgroundMitophagy Unveiled: Exploring the Nexus of Mitochondrial Health and Neuroendocrinopathy
Oyovwi, M. O., Ugwuishi, E. W., Udi, O. A., & Joseph, G. U. (2024) · Journal of Molecular Neuroscience · doi:10.1007/s12031-024-02280-w · Cited by 7
“According to a pivotal study by Song et al. in 2016, these combined actions of metformin significantly contribute to its protective effects on mitochondrial function and overall cell metabolism, providing a clearer understanding of how this medication can support metabolic health in diabetic…”
Metformin alleviates auditory cell senescence by mitophagy induction
Cho, S. I., Jo, E.-R., & Jang, H. S. (2025) · Neuroscience Research · doi:10.1016/j.neures.2025.02.008 · Cited by 6
“Previous studies have demonstrated that metformin promotes mitophagy primarily in neuro-sensory and metabolic tissues such as cerebrum, retina, and heart cells (Guo et al., 2023; Toppila et al., 2024; Song et al., 2016).”
Hara, E., Ohshima, K., Takimoto, M., Bai, Y., Hirata, M., Zeng, W., Uomoto, S., Todoroki, M., Kobayashi, M., Kozono, T., et al. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26062709 · Cited by 5
“While current research focuses on developing mitophagy-inducing drugs for the treatment of NAFLD and cancer [52–55], it is crucial to consider the potential risk of mitophagy inducers aggravating NAFLD under a certain condition.”
Li, J., Cao, X., Yuanyi, H., Li, Y., Yu, Z.-Y., Lin, M., Li, Q., Chen, J.-C., & Guo, X. (2021) · BMC Microbiology · doi:10.1186/s12866-021-02392-y · Cited by 5
“Abundant evidence revealed that cytosolic p53 could also disturb the process of mitophagy through inhibitory interaction with Parkin, a ubiquitin E3 ligase [43, 44] Zhang, Fei pointed out that the upregulation of p53 inhibited mitochondrial translocation of Parkin and activation of Parkin’s E3 ubiquitin ligase, which…”
Wass, S. Y., Barnard, J. A., Kim, H. S., Sun, H., Telfer, W., Schilling, T., Barzilai, B., Bruemmer, D., Cho, L., Huang, J. C., et al. (2024) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-024-01955-z · Cited by 5
“…fission via an AMPK mechanism, reducing mitochondrial fragmentation in mice [17], promoting mitophagy to clear dysfunctional mitochondria [18], and reducing endoplasmic reticulum (ER) stress, reactive oxygen species production, and protein synthesis, which may also reduce proteotoxic…”
Babak, M. V., Chong, K. R., Rapta, P., Ζαννίκου, Μ., Tang, H. M., Reichert, L., Chang, M. R., Kushnarev, V. A., Heffeter, P., Meier, S. M., et al. (2021) · Angewandte Chemie · doi:10.1002/ange.202102266 · Cited by 5
Naumova, N., Koliada, A. K., Kuzub, N., & Vaiserman, A. M. (2023) · Elsevier eBooks · doi:10.1016/b978-0-12-823679-6.00012-6 · Cited by 3
Tian, J.-N., Shi, X., Wang, X., Wang, S., Xu, J.-X., & Yang, C. (2017) · Molecular Medicine Reports · doi:10.3892/mmr.2017.6497 · Cited by 3
“…results of the current study demonstrated that pretreatment with astemizole (1 µM) The p53 signaling pathway has important functions in apoptosis, senescence and autophagy (19,27-29) Fibroblast growth factor-23 induces cellular senescence in human mesenchymal stem cells from skeletal muscle (30).”
Selective Autophagy as a Potential Therapeutic Target in Age-Associated Pathologies
Papandreou, M., & Tavernarakis, N. (2021) · Metabolites · doi:10.3390/metabo11090588 · Cited by 3
[Research Progress in Stress-Induced Senescence of Renal Tubular Cells in Diabetic Nephropathy].
Yi, X., He, Y., & Chen, K. (2023) · PubMed Central · doi:10.12182/20231160107 · Cited by 1
Liu, J., Li, K., Deng, Y., Li, X., Yang, R., Huang, P., Li, C., Zhao, Y., Du, F., Chen, Y., et al. (2026) · Pharmacological Research · doi:10.1016/j.phrs.2026.108410 · Cited by 1
The Importance of Autophagy and Proteostasis in Metabolic Cardiomyopathy
Islas-Carbajal, M. C., Rincón‐Sánchez, A. R., Nava-Valdivia, C. A., & Niño, C. L. C. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.92727 · Cited by 1
“has cardiovascular protective effects [91], although a recent study reported”
ResultLal, J. C., Zhou, Y., Gore-Panter, S. R., Rennison, J. H., Barnard, J., Wagoner, D. R. V., Cheng, F., & Chung, M. K. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.17.460826 · Cited by 1
Hara, E., Ohshima, K., Zeng, W., Uomoto, S., Kobayashi, M., Shibutani, M., & Yoshida, T. (2024) · Research Square · doi:10.21203/rs.3.rs-4371202/v1 · Cited by 1
Chin, G. (2005) · Science · doi:10.1126/science.307.5712.1017a
Protein Syntheses and Autophagy: In Contrast or in Synchrony?Preprint
Dioguardi, F. S., Scarabelli, C. C., Pasini, E., Corsetti, G., & Scarabelli, T. M. (2021) · Preprints.org · doi:10.20944/preprints202101.0120.v1
Lal, J. C., Mao, C., Zhou, Y., Gore-Panter, S. R., Rennison, J. H., Lovano, B. S., Castel, L., Shin, J., Gillinov, A. M., Smith, J. D., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4102637
Mitophagy inducers as potential therapeutic agents
D'Arcy, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15260-3.00004-1
Mitophagy’s impact on obesity-related tissues
Nahas, R. E., Cutanda-Tesouro, S., Espino-Guarch, M., & Garcia-Roves, P. M. (2025) · International review of cytology · doi:10.1016/bs.ircmb.2025.12.003
Metformin Ameliorates Diabetes‐Associated Cognitive Dysfunction via p53/Parkin‐Mediated Mitophagy
Xu, W., Di, L., Wang, X., 苗清和, Sun, J., Zhao, R., Xie, X., He, Y., Li, X., Zhou, Y., et al. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.71093
“Mechanistically, p53 binds to the RING0 domain of Parkin, inhibiting mitoph-agy by blocking Parkin's mitochondrial translocation [26, 61].”
Zhang, K., Chen, Y., Ran, L., Tong, W., Dai, L., Yang, Z., Chen, Q., Zheng, J., & Hu, G. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1857676
“Concurrently, metformin induces autophagy through AMPK-independent mechanisms, including STAT3 downregulation and SIRT1-mediated or Parkin-mediated mitophagy (Song et al., 2015; Song et al., 2016; Li Y. L. et al., 2019).”
Rab1A Promotes Hepatic Steatosis by Suppressing Mitophagy via the Raf‐1/ERK1/2/PINK1 Signaling Axis
Zhang, L., Li, J., Zhang, H., Qin, Q., Huang, Y., Tian, X., Sun, C., Li, B., Wang, Z., & Zhang, X. (2026) · Advanced Science · doi:10.1002/advs.202517520
Metadata
- Authors
- Song, Y., Lee, W., Lee, Y.-H., Kang, E., Cha, B.-S., & Lee, B.-W.
- Affiliations
- Yonsei University (KR)
- Division of Endocrinology and Metabolism, Department of Internal Medicine, Yonsei University College of Medicine, 03722 Seoul, Korea
- Corresponding author
- Lee, Byung-Wan
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2016-01-16
- Volume
- 17
- Issue
- 1
- Pages
- 122
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC4730363
- OpenAlex
- W2278836749
- Cited by
- 98
- References
- 27
- Citations by year
- 2026: 5 · 2025: 8 · 2024: 6 · 2023: 11 · 2022: 12 · 2021: 20 · 2020: 19 · 2019: 3 · 2018: 6 · 2017: 3 · 2016: 4
- FWCI
- 5.00
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- YUHSpace (Yonsei University Medical Library) (submittedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (2014R1A1A2057906)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Keywords
- metformin, Parkin, mitophagy, hepatic steatosis, endoplasmic reticulum stress, palmitate, high glucose, caloric restriction, ob/ob mice, pifithrin-alpha, SIRT1
- MeSH terms
- Animals, Cell Survival, Diet, Fatty Liver, Gene Expression Regulation, Glucose, Humans, Hypoglycemic Agents, Metformin, Mice, Obese, Mitochondria, Toluene, Signal Transduction, Tumor Suppressor Protein p53, Palmitic Acid, Caloric Restriction, Ubiquitin-Protein Ligases, Mice, Benzothiazoles, Sirtuin 1, Hep G2 Cells, Endoplasmic Reticulum Stress, Mitophagy
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.